Global Exosome Service 麻豆原创 Growth (Status and Outlook) 2025-2031

Publication ID:

LPI02256497

Publication Date:

March 3, 2025

Pages:

129

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

The global Exosome Service market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Exosome service refers to the provision of services related to exosomes, which are small extracellular vesicles that play a crucial role in intercellular communication. Exosomes are released by various cell types and contain proteins, lipids, and nucleic acids that can be transferred to recipient cells, influencing their function and behavior. Exosomes are small (~40鈥�150 nm) extracellular vesicles (EVs) released from all cell types and found in body fluids and cell culture supernatants. Exosomes are generated by fusion of a specialized endosome, the multivesicular body (MVB), with the plasma membrane. Exosomes have been proposed to provide means for intercellular exchange of macromolecules, allowing the transfer of proteins, lipids, mRNA and miRNA, contributing to intercellular communication in relevant biological processes, including apoptosis, antigen presentation, angiogenesis, inflammation, and coagulation. Exosomes represent a promising new frontier in drug delivery as they are non-toxic and non-immunogenic nature, and readily programmable to carry biomolecular cargoes such as nucleotides and proteins that can serve as biotherapeutics for the treatment of diseases.
Exosome services may include isolation and purification of exosomes from different biological samples, characterization of exosomes using various techniques such as electron microscopy, flow cytometry, and proteomic analysis, as well as functional studies to understand their role in specific biological processes or diseases. Additionally, exosome services may also involve exosome-based therapies, where exosomes are used as therapeutic agents for drug delivery or regenerative medicine purposes.
United States market for Exosome Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Exosome Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Exosome Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Exosome Service players cover LipExoGen Biotech, Creative Biostructure, Immunostep Biotech, AMSBIO, Frontage Labs, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淓xosome Service Industry Forecast鈥� looks at past sales and reviews total world Exosome Service sales in 2024, providing a comprehensive analysis by region and market sector of projected Exosome Service sales for 2025 through 2031. With Exosome Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Exosome Service industry.
This Insight Report provides a comprehensive analysis of the global Exosome Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Exosome Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Exosome Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Exosome Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Exosome Service.
This report presents a comprehensive overview, market shares, and growth opportunities of Exosome Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
Exosome Isolation
Exosome Identification
Exosome Analysis
Other
Segmentation by Application:
Medicine
Biological
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
LipExoGen Biotech
Creative Biostructure
Immunostep Biotech
AMSBIO
Frontage Labs
EVerZom
System Biosicences (SBI)
Exosome Diagnostics
Creative Bioarray
Exosomics
Creative Proteomics
RoosterBio
Clara Biotech
Luminous BioSciences
Capital Biosciences
Anazao
Alpha Nano Tech
NCELL
Wayen Biotechnologies (Shanghai)
Shanghai Yanjiang Biotechnology

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Exosome Service 麻豆原创 Size (2020-2031)
2.1.2 Exosome Service 麻豆原创 Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Exosome Service by Country/Region (2020, 2024 & 2031)
2.2 Exosome Service Segment by Type
2.2.1 Exosome Isolation
2.2.2 Exosome Identification
2.2.3 Exosome Analysis
2.2.4 Other
2.3 Exosome Service 麻豆原创 Size by Type
2.3.1 Exosome Service 麻豆原创 Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Exosome Service 麻豆原创 Size 麻豆原创 Share by Type (2020-2025)
2.4 Exosome Service Segment by Application
2.4.1 Medicine
2.4.2 Biological
2.4.3 Other
2.5 Exosome Service 麻豆原创 Size by Application
2.5.1 Exosome Service 麻豆原创 Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Exosome Service 麻豆原创 Size 麻豆原创 Share by Application (2020-2025)
3 Exosome Service 麻豆原创 Size by Player
3.1 Exosome Service 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Exosome Service Revenue by Player (2020-2025)
3.1.2 Global Exosome Service Revenue 麻豆原创 Share by Player (2020-2025)
3.2 Global Exosome Service Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Exosome Service by Region
4.1 Exosome Service 麻豆原创 Size by Region (2020-2025)
4.2 Global Exosome Service Annual Revenue by Country/Region (2020-2025)
4.3 Americas Exosome Service 麻豆原创 Size Growth (2020-2025)
4.4 APAC Exosome Service 麻豆原创 Size Growth (2020-2025)
4.5 Europe Exosome Service 麻豆原创 Size Growth (2020-2025)
4.6 Middle East & Africa Exosome Service 麻豆原创 Size Growth (2020-2025)
5 Americas
5.1 Americas Exosome Service 麻豆原创 Size by Country (2020-2025)
5.2 Americas Exosome Service 麻豆原创 Size by Type (2020-2025)
5.3 Americas Exosome Service 麻豆原创 Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Exosome Service 麻豆原创 Size by Region (2020-2025)
6.2 APAC Exosome Service 麻豆原创 Size by Type (2020-2025)
6.3 APAC Exosome Service 麻豆原创 Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Exosome Service 麻豆原创 Size by Country (2020-2025)
7.2 Europe Exosome Service 麻豆原创 Size by Type (2020-2025)
7.3 Europe Exosome Service 麻豆原创 Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Exosome Service by Region (2020-2025)
8.2 Middle East & Africa Exosome Service 麻豆原创 Size by Type (2020-2025)
8.3 Middle East & Africa Exosome Service 麻豆原创 Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Exosome Service 麻豆原创 Forecast
10.1 Global Exosome Service Forecast by Region (2026-2031)
10.1.1 Global Exosome Service Forecast by Region (2026-2031)
10.1.2 Americas Exosome Service Forecast
10.1.3 APAC Exosome Service Forecast
10.1.4 Europe Exosome Service Forecast
10.1.5 Middle East & Africa Exosome Service Forecast
10.2 Americas Exosome Service Forecast by Country (2026-2031)
10.2.1 United States 麻豆原创 Exosome Service Forecast
10.2.2 Canada 麻豆原创 Exosome Service Forecast
10.2.3 Mexico 麻豆原创 Exosome Service Forecast
10.2.4 Brazil 麻豆原创 Exosome Service Forecast
10.3 APAC Exosome Service Forecast by Region (2026-2031)
10.3.1 China Exosome Service 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Exosome Service Forecast
10.3.3 Korea 麻豆原创 Exosome Service Forecast
10.3.4 Southeast Asia 麻豆原创 Exosome Service Forecast
10.3.5 India 麻豆原创 Exosome Service Forecast
10.3.6 Australia 麻豆原创 Exosome Service Forecast
10.4 Europe Exosome Service Forecast by Country (2026-2031)
10.4.1 Germany 麻豆原创 Exosome Service Forecast
10.4.2 France 麻豆原创 Exosome Service Forecast
10.4.3 UK 麻豆原创 Exosome Service Forecast
10.4.4 Italy 麻豆原创 Exosome Service Forecast
10.4.5 Russia 麻豆原创 Exosome Service Forecast
10.5 Middle East & Africa Exosome Service Forecast by Region (2026-2031)
10.5.1 Egypt 麻豆原创 Exosome Service Forecast
10.5.2 South Africa 麻豆原创 Exosome Service Forecast
10.5.3 Israel 麻豆原创 Exosome Service Forecast
10.5.4 Turkey 麻豆原创 Exosome Service Forecast
10.6 Global Exosome Service Forecast by Type (2026-2031)
10.7 Global Exosome Service Forecast by Application (2026-2031)
10.7.1 GCC Countries 麻豆原创 Exosome Service Forecast
11 Key Players Analysis
11.1 LipExoGen Biotech
11.1.1 LipExoGen Biotech Company Information
11.1.2 LipExoGen Biotech Exosome Service Product Offered
11.1.3 LipExoGen Biotech Exosome Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.1.4 LipExoGen Biotech Main Business Overview
11.1.5 LipExoGen Biotech Latest Developments
11.2 Creative Biostructure
11.2.1 Creative Biostructure Company Information
11.2.2 Creative Biostructure Exosome Service Product Offered
11.2.3 Creative Biostructure Exosome Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.2.4 Creative Biostructure Main Business Overview
11.2.5 Creative Biostructure Latest Developments
11.3 Immunostep Biotech
11.3.1 Immunostep Biotech Company Information
11.3.2 Immunostep Biotech Exosome Service Product Offered
11.3.3 Immunostep Biotech Exosome Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.3.4 Immunostep Biotech Main Business Overview
11.3.5 Immunostep Biotech Latest Developments
11.4 AMSBIO
11.4.1 AMSBIO Company Information
11.4.2 AMSBIO Exosome Service Product Offered
11.4.3 AMSBIO Exosome Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.4.4 AMSBIO Main Business Overview
11.4.5 AMSBIO Latest Developments
11.5 Frontage Labs
11.5.1 Frontage Labs Company Information
11.5.2 Frontage Labs Exosome Service Product Offered
11.5.3 Frontage Labs Exosome Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.5.4 Frontage Labs Main Business Overview
11.5.5 Frontage Labs Latest Developments
11.6 EVerZom
11.6.1 EVerZom Company Information
11.6.2 EVerZom Exosome Service Product Offered
11.6.3 EVerZom Exosome Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.6.4 EVerZom Main Business Overview
11.6.5 EVerZom Latest Developments
11.7 System Biosicences (SBI)
11.7.1 System Biosicences (SBI) Company Information
11.7.2 System Biosicences (SBI) Exosome Service Product Offered
11.7.3 System Biosicences (SBI) Exosome Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.7.4 System Biosicences (SBI) Main Business Overview
11.7.5 System Biosicences (SBI) Latest Developments
11.8 Exosome Diagnostics
11.8.1 Exosome Diagnostics Company Information
11.8.2 Exosome Diagnostics Exosome Service Product Offered
11.8.3 Exosome Diagnostics Exosome Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.8.4 Exosome Diagnostics Main Business Overview
11.8.5 Exosome Diagnostics Latest Developments
11.9 Creative Bioarray
11.9.1 Creative Bioarray Company Information
11.9.2 Creative Bioarray Exosome Service Product Offered
11.9.3 Creative Bioarray Exosome Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.9.4 Creative Bioarray Main Business Overview
11.9.5 Creative Bioarray Latest Developments
11.10 Exosomics
11.10.1 Exosomics Company Information
11.10.2 Exosomics Exosome Service Product Offered
11.10.3 Exosomics Exosome Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.10.4 Exosomics Main Business Overview
11.10.5 Exosomics Latest Developments
11.11 Creative Proteomics
11.11.1 Creative Proteomics Company Information
11.11.2 Creative Proteomics Exosome Service Product Offered
11.11.3 Creative Proteomics Exosome Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.11.4 Creative Proteomics Main Business Overview
11.11.5 Creative Proteomics Latest Developments
11.12 RoosterBio
11.12.1 RoosterBio Company Information
11.12.2 RoosterBio Exosome Service Product Offered
11.12.3 RoosterBio Exosome Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.12.4 RoosterBio Main Business Overview
11.12.5 RoosterBio Latest Developments
11.13 Clara Biotech
11.13.1 Clara Biotech Company Information
11.13.2 Clara Biotech Exosome Service Product Offered
11.13.3 Clara Biotech Exosome Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.13.4 Clara Biotech Main Business Overview
11.13.5 Clara Biotech Latest Developments
11.14 Luminous BioSciences
11.14.1 Luminous BioSciences Company Information
11.14.2 Luminous BioSciences Exosome Service Product Offered
11.14.3 Luminous BioSciences Exosome Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.14.4 Luminous BioSciences Main Business Overview
11.14.5 Luminous BioSciences Latest Developments
11.15 Capital Biosciences
11.15.1 Capital Biosciences Company Information
11.15.2 Capital Biosciences Exosome Service Product Offered
11.15.3 Capital Biosciences Exosome Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.15.4 Capital Biosciences Main Business Overview
11.15.5 Capital Biosciences Latest Developments
11.16 Anazao
11.16.1 Anazao Company Information
11.16.2 Anazao Exosome Service Product Offered
11.16.3 Anazao Exosome Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.16.4 Anazao Main Business Overview
11.16.5 Anazao Latest Developments
11.17 Alpha Nano Tech
11.17.1 Alpha Nano Tech Company Information
11.17.2 Alpha Nano Tech Exosome Service Product Offered
11.17.3 Alpha Nano Tech Exosome Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.17.4 Alpha Nano Tech Main Business Overview
11.17.5 Alpha Nano Tech Latest Developments
11.18 NCELL
11.18.1 NCELL Company Information
11.18.2 NCELL Exosome Service Product Offered
11.18.3 NCELL Exosome Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.18.4 NCELL Main Business Overview
11.18.5 NCELL Latest Developments
11.19 Wayen Biotechnologies (Shanghai)
11.19.1 Wayen Biotechnologies (Shanghai) Company Information
11.19.2 Wayen Biotechnologies (Shanghai) Exosome Service Product Offered
11.19.3 Wayen Biotechnologies (Shanghai) Exosome Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.19.4 Wayen Biotechnologies (Shanghai) Main Business Overview
11.19.5 Wayen Biotechnologies (Shanghai) Latest Developments
11.20 Shanghai Yanjiang Biotechnology
11.20.1 Shanghai Yanjiang Biotechnology Company Information
11.20.2 Shanghai Yanjiang Biotechnology Exosome Service Product Offered
11.20.3 Shanghai Yanjiang Biotechnology Exosome Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.20.4 Shanghai Yanjiang Biotechnology Main Business Overview
11.20.5 Shanghai Yanjiang Biotechnology Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.